02/23/2016
https://congress.gov...
"Would you please provide the Committee with the minutes from this February 2013 meeting?"
"FDA has admitted that the proposed changes will open generic manufacturers up to greater liability under state tort lawsuits."
"The proposed rule undermines the 'sameness' requirement in Hatch-Waxman and will result in situations where multiple FDA-approved, therapeutically equivalent products will have different safety-relate..."
"The only outcome I see if the rule is enacted is mass confusion."